Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform - Business Wire
Kiyatec Inc. announced today a closing of its Series C funding round totaling US$18 million from new and existing investors. New investor Bruker (Nasd - READ MORE
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/gray/C2WLP5FQIVFKBJUOLPVMWDWRE4.jpg)
